Get Real Time Here
| Open- | Close- |
| Vol / Avg.0 / 97.794K | Mkt Cap46.037M |
| Day Range- - - | 52 Wk Range0.770 - 1.790 |
Assembly Biosciences Stock (NASDAQ:ASMB), Quotes and News Summary
Assembly Biosciences Stock (NASDAQ: ASMB) stock price, news, charts, stock research, profile.
| Open- | Close- |
| Vol / Avg.0 / 97.794K | Mkt Cap46.037M |
| Day Range- - - | 52 Wk Range0.770 - 1.790 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.290 | -0.320 | -0.0300 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-03-24 | HC Wainwright & Co. | Ed Arce | Maintains | Neutral | Lowers | 2.50 | 1.50 |
| 2022-11-16 | Mizuho | Salim Syed | Maintains | Buy | Lowers | 14.00 | 3.00 |
| 2022-10-24 | Truist Securities | Nicole Germino | Downgrades | BuyHold | Lowers | 11.00 | 2.00 |
| 2022-04-01 | Truist Securities | Nicole Germino | Maintains | Buy | Lowers | 15.00 | 12.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| ASMB | Assembly Biosciences | -1.13% | 46M |
| AGLE | Aeglea BioTherapeutics | -4.65% | 47.3M |
| HOOK | HOOKIPA Pharma | 0% | 51.7M |
| GANX | Gain Therapeutics | 14.94% | 47.9M |
| CNTB | Connect Biopharma Hldgs | -9.1% | 41M |
How do I buy Assembly Biosciences (ASMB) stock?
You can purchase shares of Assembly Biosciences (NASDAQ: ASMB) through any online brokerage.
Who are Assembly Biosciences's (ASMB) competitors?
Other companies in Assembly Biosciences’s space includes: Aeglea BioTherapeutics (NASDAQ:AGLE), HOOKIPA Pharma (NASDAQ:HOOK), Gain Therapeutics (NASDAQ:GANX), Connect Biopharma Hldgs (NASDAQ:CNTB) and Vistagen Therapeutics (NASDAQ:VTGN).
What is the target price for Assembly Biosciences (ASMB) stock?
The latest price target for Assembly Biosciences (NASDAQ: ASMB) was reported by HC Wainwright & Co. on Friday, March 24, 2023. The analyst firm set a price target for 1.50 expecting ASMB to rise to within 12 months (a possible 71.43% upside). 3 analyst firms have reported ratings in the last year.
Current Stock Price for Assembly Biosciences (ASMB)?
The stock price for Assembly Biosciences (NASDAQ: ASMB) is $0.875 last updated September 27, 2023 at 9:21 PM UTC.
Does Assembly Biosciences (ASMB) pay a dividend?
There is no dividend information for Assembly Biosciences.
When is Assembly Biosciences (NASDAQ:ASMB) reporting earnings?
Assembly Biosciences’s Q3 earnings are confirmed for Tuesday, November 7, 2023.
Is Assembly Biosciences (ASMB) going to split?
There is no upcoming split for Assembly Biosciences.
What sector and industry does Assembly Biosciences (ASMB) operate in?
Assembly Biosciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Assembly Biosciences Stock (NASDAQ:ASMB), Quotes and News Summary
Assembly Biosciences Stock (NASDAQ: ASMB) stock price, news, charts, stock research, profile.
| Open- | Close- |
| Vol / Avg.0 / 97.794K | Mkt Cap46.037M |
| Day Range- - - | 52 Wk Range0.770 - 1.790 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.290 | -0.320 | -0.0300 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-03-24 | HC Wainwright & Co. | Ed Arce | Maintains | Neutral | Lowers | 2.50 | 1.50 |
| 2022-11-16 | Mizuho | Salim Syed | Maintains | Buy | Lowers | 14.00 | 3.00 |
| 2022-10-24 | Truist Securities | Nicole Germino | Downgrades | BuyHold | Lowers | 11.00 | 2.00 |
| 2022-04-01 | Truist Securities | Nicole Germino | Maintains | Buy | Lowers | 15.00 | 12.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| ASMB | Assembly Biosciences | -1.13% | 46M |
| AGLE | Aeglea BioTherapeutics | -4.65% | 47.3M |
| HOOK | HOOKIPA Pharma | 0% | 51.7M |
| GANX | Gain Therapeutics | 14.94% | 47.9M |
| CNTB | Connect Biopharma Hldgs | -9.1% | 41M |
How do I buy Assembly Biosciences (ASMB) stock?
You can purchase shares of Assembly Biosciences (NASDAQ: ASMB) through any online brokerage.
Who are Assembly Biosciences's (ASMB) competitors?
Other companies in Assembly Biosciences’s space includes: Aeglea BioTherapeutics (NASDAQ:AGLE), HOOKIPA Pharma (NASDAQ:HOOK), Gain Therapeutics (NASDAQ:GANX), Connect Biopharma Hldgs (NASDAQ:CNTB) and Vistagen Therapeutics (NASDAQ:VTGN).
What is the target price for Assembly Biosciences (ASMB) stock?
The latest price target for Assembly Biosciences (NASDAQ: ASMB) was reported by HC Wainwright & Co. on Friday, March 24, 2023. The analyst firm set a price target for 1.50 expecting ASMB to rise to within 12 months (a possible 71.43% upside). 3 analyst firms have reported ratings in the last year.
Current Stock Price for Assembly Biosciences (ASMB)?
The stock price for Assembly Biosciences (NASDAQ: ASMB) is $0.875 last updated September 27, 2023 at 9:21 PM UTC.
Does Assembly Biosciences (ASMB) pay a dividend?
There is no dividend information for Assembly Biosciences.
When is Assembly Biosciences (NASDAQ:ASMB) reporting earnings?
Assembly Biosciences’s Q3 earnings are confirmed for Tuesday, November 7, 2023.
Is Assembly Biosciences (ASMB) going to split?
There is no upcoming split for Assembly Biosciences.
What sector and industry does Assembly Biosciences (ASMB) operate in?
Assembly Biosciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Assembly Biosciences Stock (NASDAQ:ASMB), Quotes and News Summary
Assembly Biosciences Stock (NASDAQ: ASMB) stock price, news, charts, stock research, profile.
| Open- | Close- |
| Vol / Avg.0 / 97.794K | Mkt Cap46.037M |
| Day Range- - - | 52 Wk Range0.770 - 1.790 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.290 | -0.320 | -0.0300 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-03-24 | HC Wainwright & Co. | Ed Arce | Maintains | Neutral | Lowers | 2.50 | 1.50 |
| 2022-11-16 | Mizuho | Salim Syed | Maintains | Buy | Lowers | 14.00 | 3.00 |
| 2022-10-24 | Truist Securities | Nicole Germino | Downgrades | BuyHold | Lowers | 11.00 | 2.00 |
| 2022-04-01 | Truist Securities | Nicole Germino | Maintains | Buy | Lowers | 15.00 | 12.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| ASMB | Assembly Biosciences | -1.13% | 46M |
| AGLE | Aeglea BioTherapeutics | -4.65% | 47.3M |
| HOOK | HOOKIPA Pharma | 0% | 51.7M |
| GANX | Gain Therapeutics | 14.94% | 47.9M |
| CNTB | Connect Biopharma Hldgs | -9.1% | 41M |
How do I buy Assembly Biosciences (ASMB) stock?
You can purchase shares of Assembly Biosciences (NASDAQ: ASMB) through any online brokerage.
Who are Assembly Biosciences's (ASMB) competitors?
Other companies in Assembly Biosciences’s space includes: Aeglea BioTherapeutics (NASDAQ:AGLE), HOOKIPA Pharma (NASDAQ:HOOK), Gain Therapeutics (NASDAQ:GANX), Connect Biopharma Hldgs (NASDAQ:CNTB) and Vistagen Therapeutics (NASDAQ:VTGN).
What is the target price for Assembly Biosciences (ASMB) stock?
The latest price target for Assembly Biosciences (NASDAQ: ASMB) was reported by HC Wainwright & Co. on Friday, March 24, 2023. The analyst firm set a price target for 1.50 expecting ASMB to rise to within 12 months (a possible 71.43% upside). 3 analyst firms have reported ratings in the last year.
Current Stock Price for Assembly Biosciences (ASMB)?
The stock price for Assembly Biosciences (NASDAQ: ASMB) is $0.875 last updated September 27, 2023 at 9:21 PM UTC.
Does Assembly Biosciences (ASMB) pay a dividend?
There is no dividend information for Assembly Biosciences.
When is Assembly Biosciences (NASDAQ:ASMB) reporting earnings?
Assembly Biosciences’s Q3 earnings are confirmed for Tuesday, November 7, 2023.
Is Assembly Biosciences (ASMB) going to split?
There is no upcoming split for Assembly Biosciences.
What sector and industry does Assembly Biosciences (ASMB) operate in?
Assembly Biosciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Assembly Biosciences Stock (NASDAQ:ASMB), Quotes and News Summary
Assembly Biosciences Stock (NASDAQ: ASMB) stock price, news, charts, stock research, profile.
| Open- | Close- |
| Vol / Avg.0 / 97.794K | Mkt Cap46.037M |
| Day Range- - - | 52 Wk Range0.770 - 1.790 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.290 | -0.320 | -0.0300 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-03-24 | HC Wainwright & Co. | Ed Arce | Maintains | Neutral | Lowers | 2.50 | 1.50 |
| 2022-11-16 | Mizuho | Salim Syed | Maintains | Buy | Lowers | 14.00 | 3.00 |
| 2022-10-24 | Truist Securities | Nicole Germino | Downgrades | BuyHold | Lowers | 11.00 | 2.00 |
| 2022-04-01 | Truist Securities | Nicole Germino | Maintains | Buy | Lowers | 15.00 | 12.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| ASMB | Assembly Biosciences | -1.13% | 46M |
| AGLE | Aeglea BioTherapeutics | -4.65% | 47.3M |
| HOOK | HOOKIPA Pharma | 0% | 51.7M |
| GANX | Gain Therapeutics | 14.94% | 47.9M |
| CNTB | Connect Biopharma Hldgs | -9.1% | 41M |
How do I buy Assembly Biosciences (ASMB) stock?
You can purchase shares of Assembly Biosciences (NASDAQ: ASMB) through any online brokerage.
Who are Assembly Biosciences's (ASMB) competitors?
Other companies in Assembly Biosciences’s space includes: Aeglea BioTherapeutics (NASDAQ:AGLE), HOOKIPA Pharma (NASDAQ:HOOK), Gain Therapeutics (NASDAQ:GANX), Connect Biopharma Hldgs (NASDAQ:CNTB) and Vistagen Therapeutics (NASDAQ:VTGN).
What is the target price for Assembly Biosciences (ASMB) stock?
The latest price target for Assembly Biosciences (NASDAQ: ASMB) was reported by HC Wainwright & Co. on Friday, March 24, 2023. The analyst firm set a price target for 1.50 expecting ASMB to rise to within 12 months (a possible 71.43% upside). 3 analyst firms have reported ratings in the last year.
Current Stock Price for Assembly Biosciences (ASMB)?
The stock price for Assembly Biosciences (NASDAQ: ASMB) is $0.875 last updated September 27, 2023 at 9:21 PM UTC.
Does Assembly Biosciences (ASMB) pay a dividend?
There is no dividend information for Assembly Biosciences.
When is Assembly Biosciences (NASDAQ:ASMB) reporting earnings?
Assembly Biosciences’s Q3 earnings are confirmed for Tuesday, November 7, 2023.
Is Assembly Biosciences (ASMB) going to split?
There is no upcoming split for Assembly Biosciences.
What sector and industry does Assembly Biosciences (ASMB) operate in?
Assembly Biosciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Assembly Biosciences Stock (NASDAQ:ASMB), Quotes and News Summary
Assembly Biosciences Stock (NASDAQ: ASMB) stock price, news, charts, stock research, profile.
| Open- | Close- |
| Vol / Avg.0 / 97.794K | Mkt Cap46.037M |
| Day Range- - - | 52 Wk Range0.770 - 1.790 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.290 | -0.320 | -0.0300 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-03-24 | HC Wainwright & Co. | Ed Arce | Maintains | Neutral | Lowers | 2.50 | 1.50 |
| 2022-11-16 | Mizuho | Salim Syed | Maintains | Buy | Lowers | 14.00 | 3.00 |
| 2022-10-24 | Truist Securities | Nicole Germino | Downgrades | BuyHold | Lowers | 11.00 | 2.00 |
| 2022-04-01 | Truist Securities | Nicole Germino | Maintains | Buy | Lowers | 15.00 | 12.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| ASMB | Assembly Biosciences | -1.13% | 46M |
| AGLE | Aeglea BioTherapeutics | -4.65% | 47.3M |
| HOOK | HOOKIPA Pharma | 0% | 51.7M |
| GANX | Gain Therapeutics | 14.94% | 47.9M |
| CNTB | Connect Biopharma Hldgs | -9.1% | 41M |
How do I buy Assembly Biosciences (ASMB) stock?
You can purchase shares of Assembly Biosciences (NASDAQ: ASMB) through any online brokerage.
Who are Assembly Biosciences's (ASMB) competitors?
Other companies in Assembly Biosciences’s space includes: Aeglea BioTherapeutics (NASDAQ:AGLE), HOOKIPA Pharma (NASDAQ:HOOK), Gain Therapeutics (NASDAQ:GANX), Connect Biopharma Hldgs (NASDAQ:CNTB) and Vistagen Therapeutics (NASDAQ:VTGN).
What is the target price for Assembly Biosciences (ASMB) stock?
The latest price target for Assembly Biosciences (NASDAQ: ASMB) was reported by HC Wainwright & Co. on Friday, March 24, 2023. The analyst firm set a price target for 1.50 expecting ASMB to rise to within 12 months (a possible 71.43% upside). 3 analyst firms have reported ratings in the last year.
Current Stock Price for Assembly Biosciences (ASMB)?
The stock price for Assembly Biosciences (NASDAQ: ASMB) is $0.875 last updated September 27, 2023 at 9:21 PM UTC.
Does Assembly Biosciences (ASMB) pay a dividend?
There is no dividend information for Assembly Biosciences.
When is Assembly Biosciences (NASDAQ:ASMB) reporting earnings?
Assembly Biosciences’s Q3 earnings are confirmed for Tuesday, November 7, 2023.
Is Assembly Biosciences (ASMB) going to split?
There is no upcoming split for Assembly Biosciences.
What sector and industry does Assembly Biosciences (ASMB) operate in?
Assembly Biosciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Assembly Biosciences Stock (NASDAQ:ASMB), Quotes and News Summary
Assembly Biosciences Stock (NASDAQ: ASMB) stock price, news, charts, stock research, profile.
| Open- | Close- |
| Vol / Avg.0 / 97.794K | Mkt Cap46.037M |
| Day Range- - - | 52 Wk Range0.770 - 1.790 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.290 | -0.320 | -0.0300 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-03-24 | HC Wainwright & Co. | Ed Arce | Maintains | Neutral | Lowers | 2.50 | 1.50 |
| 2022-11-16 | Mizuho | Salim Syed | Maintains | Buy | Lowers | 14.00 | 3.00 |
| 2022-10-24 | Truist Securities | Nicole Germino | Downgrades | BuyHold | Lowers | 11.00 | 2.00 |
| 2022-04-01 | Truist Securities | Nicole Germino | Maintains | Buy | Lowers | 15.00 | 12.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| ASMB | Assembly Biosciences | -1.13% | 46M |
| AGLE | Aeglea BioTherapeutics | -4.65% | 47.3M |
| HOOK | HOOKIPA Pharma | 0% | 51.7M |
| GANX | Gain Therapeutics | 14.94% | 47.9M |
| CNTB | Connect Biopharma Hldgs | -9.1% | 41M |
How do I buy Assembly Biosciences (ASMB) stock?
You can purchase shares of Assembly Biosciences (NASDAQ: ASMB) through any online brokerage.
Who are Assembly Biosciences's (ASMB) competitors?
Other companies in Assembly Biosciences’s space includes: Aeglea BioTherapeutics (NASDAQ:AGLE), HOOKIPA Pharma (NASDAQ:HOOK), Gain Therapeutics (NASDAQ:GANX), Connect Biopharma Hldgs (NASDAQ:CNTB) and Vistagen Therapeutics (NASDAQ:VTGN).
What is the target price for Assembly Biosciences (ASMB) stock?
The latest price target for Assembly Biosciences (NASDAQ: ASMB) was reported by HC Wainwright & Co. on Friday, March 24, 2023. The analyst firm set a price target for 1.50 expecting ASMB to rise to within 12 months (a possible 71.43% upside). 3 analyst firms have reported ratings in the last year.
Current Stock Price for Assembly Biosciences (ASMB)?
The stock price for Assembly Biosciences (NASDAQ: ASMB) is $0.875 last updated September 27, 2023 at 9:21 PM UTC.
Does Assembly Biosciences (ASMB) pay a dividend?
There is no dividend information for Assembly Biosciences.
When is Assembly Biosciences (NASDAQ:ASMB) reporting earnings?
Assembly Biosciences’s Q3 earnings are confirmed for Tuesday, November 7, 2023.
Is Assembly Biosciences (ASMB) going to split?
There is no upcoming split for Assembly Biosciences.
What sector and industry does Assembly Biosciences (ASMB) operate in?
Assembly Biosciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Assembly Biosciences Stock (NASDAQ:ASMB), Quotes and News Summary
Assembly Biosciences Stock (NASDAQ: ASMB) stock price, news, charts, stock research, profile.
| Open- | Close- |
| Vol / Avg.0 / 97.794K | Mkt Cap46.037M |
| Day Range- - - | 52 Wk Range0.770 - 1.790 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.290 | -0.320 | -0.0300 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-03-24 | HC Wainwright & Co. | Ed Arce | Maintains | Neutral | Lowers | 2.50 | 1.50 |
| 2022-11-16 | Mizuho | Salim Syed | Maintains | Buy | Lowers | 14.00 | 3.00 |
| 2022-10-24 | Truist Securities | Nicole Germino | Downgrades | BuyHold | Lowers | 11.00 | 2.00 |
| 2022-04-01 | Truist Securities | Nicole Germino | Maintains | Buy | Lowers | 15.00 | 12.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| ASMB | Assembly Biosciences | -1.13% | 46M |
| AGLE | Aeglea BioTherapeutics | -4.65% | 47.3M |
| HOOK | HOOKIPA Pharma | 0% | 51.7M |
| GANX | Gain Therapeutics | 14.94% | 47.9M |
| CNTB | Connect Biopharma Hldgs | -9.1% | 41M |
How do I buy Assembly Biosciences (ASMB) stock?
You can purchase shares of Assembly Biosciences (NASDAQ: ASMB) through any online brokerage.
Who are Assembly Biosciences's (ASMB) competitors?
Other companies in Assembly Biosciences’s space includes: Aeglea BioTherapeutics (NASDAQ:AGLE), HOOKIPA Pharma (NASDAQ:HOOK), Gain Therapeutics (NASDAQ:GANX), Connect Biopharma Hldgs (NASDAQ:CNTB) and Vistagen Therapeutics (NASDAQ:VTGN).
What is the target price for Assembly Biosciences (ASMB) stock?
The latest price target for Assembly Biosciences (NASDAQ: ASMB) was reported by HC Wainwright & Co. on Friday, March 24, 2023. The analyst firm set a price target for 1.50 expecting ASMB to rise to within 12 months (a possible 71.43% upside). 3 analyst firms have reported ratings in the last year.
Current Stock Price for Assembly Biosciences (ASMB)?
The stock price for Assembly Biosciences (NASDAQ: ASMB) is $0.875 last updated September 27, 2023 at 9:21 PM UTC.
Does Assembly Biosciences (ASMB) pay a dividend?
There is no dividend information for Assembly Biosciences.
When is Assembly Biosciences (NASDAQ:ASMB) reporting earnings?
Assembly Biosciences’s Q3 earnings are confirmed for Tuesday, November 7, 2023.
Is Assembly Biosciences (ASMB) going to split?
There is no upcoming split for Assembly Biosciences.
What sector and industry does Assembly Biosciences (ASMB) operate in?
Assembly Biosciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Assembly Biosciences Stock (NASDAQ:ASMB), Quotes and News Summary
Assembly Biosciences Stock (NASDAQ: ASMB) stock price, news, charts, stock research, profile.
| Open- | Close- |
| Vol / Avg.0 / 97.794K | Mkt Cap46.037M |
| Day Range- - - | 52 Wk Range0.770 - 1.790 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.290 | -0.320 | -0.0300 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-03-24 | HC Wainwright & Co. | Ed Arce | Maintains | Neutral | Lowers | 2.50 | 1.50 |
| 2022-11-16 | Mizuho | Salim Syed | Maintains | Buy | Lowers | 14.00 | 3.00 |
| 2022-10-24 | Truist Securities | Nicole Germino | Downgrades | BuyHold | Lowers | 11.00 | 2.00 |
| 2022-04-01 | Truist Securities | Nicole Germino | Maintains | Buy | Lowers | 15.00 | 12.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| ASMB | Assembly Biosciences | -1.13% | 46M |
| AGLE | Aeglea BioTherapeutics | -4.65% | 47.3M |
| HOOK | HOOKIPA Pharma | 0% | 51.7M |
| GANX | Gain Therapeutics | 14.94% | 47.9M |
| CNTB | Connect Biopharma Hldgs | -9.1% | 41M |
How do I buy Assembly Biosciences (ASMB) stock?
You can purchase shares of Assembly Biosciences (NASDAQ: ASMB) through any online brokerage.
Who are Assembly Biosciences's (ASMB) competitors?
Other companies in Assembly Biosciences’s space includes: Aeglea BioTherapeutics (NASDAQ:AGLE), HOOKIPA Pharma (NASDAQ:HOOK), Gain Therapeutics (NASDAQ:GANX), Connect Biopharma Hldgs (NASDAQ:CNTB) and Vistagen Therapeutics (NASDAQ:VTGN).
What is the target price for Assembly Biosciences (ASMB) stock?
The latest price target for Assembly Biosciences (NASDAQ: ASMB) was reported by HC Wainwright & Co. on Friday, March 24, 2023. The analyst firm set a price target for 1.50 expecting ASMB to rise to within 12 months (a possible 71.43% upside). 3 analyst firms have reported ratings in the last year.
Current Stock Price for Assembly Biosciences (ASMB)?
The stock price for Assembly Biosciences (NASDAQ: ASMB) is $0.875 last updated September 27, 2023 at 9:21 PM UTC.
Does Assembly Biosciences (ASMB) pay a dividend?
There is no dividend information for Assembly Biosciences.
When is Assembly Biosciences (NASDAQ:ASMB) reporting earnings?
Assembly Biosciences’s Q3 earnings are confirmed for Tuesday, November 7, 2023.
Is Assembly Biosciences (ASMB) going to split?
There is no upcoming split for Assembly Biosciences.
What sector and industry does Assembly Biosciences (ASMB) operate in?
Assembly Biosciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Assembly Biosciences Stock (NASDAQ:ASMB), Quotes and News Summary
Assembly Biosciences Stock (NASDAQ: ASMB) stock price, news, charts, stock research, profile.
| Open- | Close- |
| Vol / Avg.0 / 97.794K | Mkt Cap46.037M |
| Day Range- - - | 52 Wk Range0.770 - 1.790 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.290 | -0.320 | -0.0300 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-03-24 | HC Wainwright & Co. | Ed Arce | Maintains | Neutral | Lowers | 2.50 | 1.50 |
| 2022-11-16 | Mizuho | Salim Syed | Maintains | Buy | Lowers | 14.00 | 3.00 |
| 2022-10-24 | Truist Securities | Nicole Germino | Downgrades | BuyHold | Lowers | 11.00 | 2.00 |
| 2022-04-01 | Truist Securities | Nicole Germino | Maintains | Buy | Lowers | 15.00 | 12.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| ASMB | Assembly Biosciences | -1.13% | 46M |
| AGLE | Aeglea BioTherapeutics | -4.65% | 47.3M |
| HOOK | HOOKIPA Pharma | 0% | 51.7M |
| GANX | Gain Therapeutics | 14.94% | 47.9M |
| CNTB | Connect Biopharma Hldgs | -9.1% | 41M |
How do I buy Assembly Biosciences (ASMB) stock?
You can purchase shares of Assembly Biosciences (NASDAQ: ASMB) through any online brokerage.
Who are Assembly Biosciences's (ASMB) competitors?
Other companies in Assembly Biosciences’s space includes: Aeglea BioTherapeutics (NASDAQ:AGLE), HOOKIPA Pharma (NASDAQ:HOOK), Gain Therapeutics (NASDAQ:GANX), Connect Biopharma Hldgs (NASDAQ:CNTB) and Vistagen Therapeutics (NASDAQ:VTGN).
What is the target price for Assembly Biosciences (ASMB) stock?
The latest price target for Assembly Biosciences (NASDAQ: ASMB) was reported by HC Wainwright & Co. on Friday, March 24, 2023. The analyst firm set a price target for 1.50 expecting ASMB to rise to within 12 months (a possible 71.43% upside). 3 analyst firms have reported ratings in the last year.
Current Stock Price for Assembly Biosciences (ASMB)?
The stock price for Assembly Biosciences (NASDAQ: ASMB) is $0.875 last updated September 27, 2023 at 9:21 PM UTC.
Does Assembly Biosciences (ASMB) pay a dividend?
There is no dividend information for Assembly Biosciences.
When is Assembly Biosciences (NASDAQ:ASMB) reporting earnings?
Assembly Biosciences’s Q3 earnings are confirmed for Tuesday, November 7, 2023.
Is Assembly Biosciences (ASMB) going to split?
There is no upcoming split for Assembly Biosciences.
What sector and industry does Assembly Biosciences (ASMB) operate in?
Assembly Biosciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.